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Abstract: Neurotrophins are secreted proteins that regulate neuronal development and 
survival, as well as maintenance and plasticity of the adult nervous system. The biological 
activity of neurotrophins stems from their binding to two membrane receptor types, the 
tropomyosin receptor kinase and the p75 neurotrophin receptors (NRs). The intracellular 
signalling cascades thereby activated have been extensively investigated. Nevertheless, a 
comprehensive description of the ligand-induced nanoscale details of NRs dynamics and 
interactions spanning from the initial lateral movements triggered at the plasma membrane 
to the internalization and transport processes is still missing. Recent advances in high 
spatio-temporal resolution imaging techniques have yielded new insight on the dynamics 
of NRs upon ligand binding. Here we discuss requirements, potential and practical 
implementation of these novel approaches for the study of neurotrophin trafficking and 
signalling, in the framework of current knowledge available also for other ligand-receptor 
systems. We shall especially highlight the correlation between the receptor dynamics 
activated by different neurotrophins and the respective signalling outcome, as recently 
revealed by single-molecule tracking of NRs in living neuronal cells. 
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1. Introduction 
Neurotrophins (NTs) are a family of neuronal growth factors that crucially regulate cell survival, 
differentiation, neurite outgrowth, as well as cell maintenance, neurite regeneration and synaptic 
plasticity in both the central and peripheral nervous system (CNS and PNS, respectively) [1,2]. NTs 
are synthesized as long precursors (pre-proNTs) that contain a ~2 kDa signal peptide for protein 
secretion (pre-peptide). The latter is cleaved upon translocation into the endoplasmic reticulum and 
yields the ~30 kDa precursor proteins (proNTs) that rapidly associate as non-covalent homodimers. 
The pro-sequence is cleaved at a highly conserved dibasic amino acid site either in the trans-Golgi 
network by furin protease and pro-convertases or, once secreted, in the extracellular space by plasmin 
or other matrix metalloproteases giving the mature, homodimeric ~26 kDa (13 kDa per monomer)  
NT [3–6]. Under physiological conditions, NTs are typically produced and secreted by non-neuronal 
tissues or by neurons (defined as “targets”) in the PNS and CNS, respectively. When released by 
postsynaptic targets, NTs bind receptors on nerve terminals of presynaptic NT-sensitive neurons [7,8]. 
Although recent studies indicate that autocrine and non-target-derived paracrine modes of NT 
presentation are also likely to be important [7,9,10], target-derived NT actions were the most 
intensively studied in the latest years. It is now well established that NTs bind specific receptors at the 
neuronal distal compartments and the activated complexes thereby formed can signal both locally 
(where they control growth-cone motility) and retrogradely through long axons up to distant cell 
bodies (where they promote gene expression and survival). Indeed retrograde signalling is the main 
mechanism regulating the survival/degeneration switch during development and, once started, it must 
continue for the lifespan of a neuron to maintain its functional differentiated state [7,8,11–15]. 
More than fifty years after the discovery of the nerve growth factor (NGF) [16,17], the first and best 
characterized NT, and thirty years after the discovery of its retrograde transport [18,19], it is still 
surprising that these factors exert their multitude of biological functions mostly by binding only two 
types of membrane receptors, hereafter referred to as neurotrophin receptors (NRs): the tropomyosin 
receptor kinases (Trks) and the p75 neurotrophin receptor (p75NTR) [20–26]. Figure 1 schematically 
shows these two NRs and highlights the lack of relation between their structures. Trks belong to  
the receptor tyrosine kinase (RTK) family: these are traditionally known to dimerize upon ligand 
binding, thus activating the trans-phosphorylation of the intracellular kinase domains, and additional 
phosphorylation of intracellular effectors; alternatively, there is increasing evidence that many RTK 
members exist as dimers or clusters also in the absence of ligands, and the dimers can be active, 
eventually stabilized by ligand binding and/or primed for ligand-induced activation [27]. For the Trks 
such activation mechanisms ensue in mostly neurotrophic and survival responses [22]. On the other 
hand, p75NTR is a member of the tumor necrosis factor receptor (TNFR) superfamily: It has no 
intracellular enzymatic activity and is best known for mediating neural-cell death during development 
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as well as in the adult following injury [25,28,29]. The specification of differential neuron-specific 
actions is achieved by NT binding to NRs using a number of different but interlaced molecular 
mechanisms, the main of which will be listed in the following. 
Different NTs selectively recognize different Trks; mammals express four NTs, namely  
NGF, brain-derived growth factor (BDNF), neurotrophin 3 (NT-3) and neurotrophin 4/5 (NT-4/5). 
They bind specifically to TrkA (NGF), TrkB (BDNF and NT-4) and TrkC (NT-3) receptors.  
NT-3 also binds to TrkA and TrkB, although with less affinity and activating distinct signalling 
outcomes [22,23]. Thus, a first level of specificity relies on the different Trk-expression profile in 
distinct subsets of peripheral and central neurons. Individual neurons may be responsive to more than 
one NT at a given time or at subsequent times during development [30,31]; importantly, various 
splicing isoforms of the three Trks were reported that display both altered ligand-binding affinity for 
the different NTs and subsequent activation of distinct signalling pathways [22,23]. 
 
Figure 1. Schematic picture of tropomyosin receptor kinases (Trks) and the p75 
neurotrophin receptors (p75NTR). (A) Structure of the two receptors: The intracellular (on 
top) and extracellular (on bottom) domains are highlighted. The following abbreviations are 
used: CRD (cystein-rich domain); LRR (leucine-rich domain); IgL-D (immunoglobulin-like 
domain); TKD (tyrosine-kinase domain); CD (chopper domain); DD (death domain);  
(B) Modified residues of the Trks (on top) and of p75NTR (on bottom) receptors.  
The following abbreviations are used: TM (transmembrane domain); JM (juxta-membrane 
domain); N (N-terminus); C (C-terminus). The following symbols are used: Grey ↓ (N- or 
O-glycosylation sites); green ↓ (ATP-binding site); red ↓ (site of covalent homo-dimerization 
due to the disulfide bond formed by Cys257 [32,33]). U (ubiquitination-related lysine 
residues, as derived from studies mainly performed on the TrkA receptor [34–37]);  
Y (phosphorylated tyrosine residues, their numeration and function is described in Figure 2);  
P (palmitoylated Cys residue [38]). 
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The presence of p75NTR as an alternative and/or cognate NGF receptor greatly influences  
ligand-binding specificity and the subsequent signalling outcome. The functional interplay between 
Trks and p75NTR has been debated for a long time. The first pioneering study of the field described 
that when p75NTR is co-expressed with TrkA, mature NGF binds to the complex with higher affinity 
than with either receptor alone [39]. Moreover, p75NTR co-expressed with Trks was found to enhance 
the selectivity of Trk recognition by NTs [40]. Conversely, p75NTR expressed alone was found to 
induce death upon NGF binding in different cells of the CNS [41,42]. Therefore, as physiologically 
TrkA and p75NTR co-exist at various reciprocal expression levels in different neurons and during 
different stages of neuronal development [43,44], the ratio of p75NTR to Trks was linked to the 
decision between survival and death among NGF-responsive neurons [45]. Accordingly, such ratio 
was also shown to regulate the number of high-affinity NGF binding sites, which are responsible for  
a survival-signalling outcome [46]. However, while enhancement of NGF-affinity to TrkA by p75NTR 
is well documented, the mechanism by which this occurs is not obvious from the analysis of the 
available crystal-structure data [47–51]. Over the last twenty years, several mechanistic models for the 
functional complex formed by TrkA with p75NTR upon NGF binding were proposed, the latest of 
which is the ligand-passing model in which p75NTR first binds to NGF and then releases the ligand to 
TrkA [51]. This model does not take into account a previous observation that the extracellular  
ligand-binding domain of p75NTR and therefore NGF binding by p75NTR are not required to create 
high-affinity NGF binding sites [46]. This evidence was recently corroborated by the observation that  
a p75NTR intracellular domain fragment formed upon processing by secretase proteases, but not the 
full-length p75NTR, enhances NGF binding to TrkA [52]. These observations are suggestive of 
receptor-receptor interactions likely involving the transmembrane and/or cytoplasmic domains of TrkA 
and p75NTR. In any case, unambiguous evidence for the existence, stoichiometry and nature of  
a ternary TrkA-NGF-p75NTR complex is still lacking. An additional layer of complexity was added 
by the discovery that the precursor forms of NTs, proNTs, display much higher affinity for p75NTR 
than the respective NTs. They induce p75NTR-dependent apoptosis in cultured neurons at a much 
lower dose compared to the respective NTs and with minimal activation of TrkA-mediated 
differentiation or survival [53]. It was later discovered that proNGF creates a signalling complex by 
simultaneously binding to p75NTR and sortilin, a member of the family of Vps10p-domain receptors, 
with the pro-region making contacts with sortilin and the mature part with p75NTR [53–55].  
To summarize, it is today well established that although all NTs bind to the p75NTR receptor with the 
same affinity, the resulting biological outcome depends on the relative Trk/p75NTR expression levels 
and on the presence of other ligands (especially precursor NTs) and other co-receptors for p75NTR 
besides Trks, e.g., sortilin [5,20,23,24]. Indeed, proNTs preferentially activate p75NTR to mediate 
apoptosis while mature forms activate Trks to promote survival. 
NT-NR activated complexes formed in various neuronal subtypes assemble into distinct types of 
endosomes to differentiate signal-transduction pathways. This conclusion was extensively reviewed  
by Bronfman et al. [10] and arises from several independent observations that mutations and/or 
alterations of the endosome trafficking and sorting properties displayed by specific neuronal 
subpopulations result in distinct neurodegenerative diseases. According to this hypothesis, also supported 
by Matusica et al. [11], the signalling activity of activated NRs relies not only on the NT-NR 
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molecular complexes formed upon ligand-binding, but also on the fate of such complexes once 
internalized; in this context, endocytosis and endosome sorting are expected to play a major role. 
Many of the signalling cascades, pathways and effectors underpinning the above-described molecular 
mechanisms were identified: They are beyond the scope of this review and were thoroughly reviewed 
elsewhere [5,7,9,10,20–24,26,51]. Nevertheless, how different types of NTs and different types of  
NRs are co-ordinately working to produce variable behaviours in different neuronal cells is still  
largely unknown. In particular, the nanoscale details of molecular specificity achieved by NRs  
upon recognition of different available NTs and/or their respective unprocessed forms are poorly 
understood. This information would likely provide the mechanistic link between the initial lateral 
movements triggered at the plasma membrane upon ligand binding, their internalization and transport 
processes, and their respective biological outcome. This in turn would yield a comprehensive 
understanding of NT function and open the way to the rational design of targeted pharmacological 
approaches [26]. Here, we focus on recently-developed advanced imaging approaches—with particular 
emphasis on single-molecule imaging and tracking—applied to the study of the NT-NR dynamic 
interplay in the physiological context of living cells. We shall discuss the requirements and potential of 
such approaches, and why they are particularly suited to address questions such as receptor clustering 
at the cell membrane and binding stoichiometry of molecular complexes. We shall also review to what 
extent these biophysical tools were so far applied to gain new molecular details about NT trafficking 
and signaling. In particular, we shall discuss the recent observation made possible by single-molecule 
tracking of NRs, that a correlation exists between receptor membrane dynamics activated by different 
NTs and the respective signaling outcome. The dynamic behavior of NRs will also be discussed in 
comparison to other similar ligand-receptor systems that were also investigated using similar approaches. 
2. Advanced Live-Cell Imaging Approaches for the Detection of Molecular Interactions and 
Single-Molecule Dynamics 
Progress in fluorescence imaging is enabling the study of biological events with increasingly high 
detail thanks to novel microscopy techniques that provide imaging and mapping of several dynamic 
processes at both cellular and molecular level. Concurrently, several fluorescent probes were developed 
spanning from fluorescent proteins (FPs) and other protein tags, to organic dyes and nanocrystals that 
enable the noninvasive study of a large number of cellular processes [56–61]. Nowadays there is  
a growing list of fluorescence-imaging approaches that can be considered “advanced” in that they offer 
resolution close to or beyond the light diffraction limit and monitor dynamics occurring down to the 
sub-ms time scale [62–67]. Among advanced microscopy techniques that have been used to study NRs, 
we shall distinguish between two approaches that address complementary aspects of their NR dynamics 
in living cells: (i) Homo- or hetero-interactions involving NRs at the molecular scale; and (ii) membrane 
or intracellular dynamics and trafficking of NRs in either resting or ligand-stimulated conditions. 
Most of the studies concerning molecular interactions occurring amongst NRs used Förster resonance 
energy transfer (FRET) imaging [68–71]. This method exploits the non-radiative energy transfer  
(due to dipole-dipole coupling) from an excited molecular fluorophore (donor) to another one (acceptor) 
with absorption spectrum at latter partially overlapping the emission of the donor. Donor and acceptor 
can be the same fluorophore in the case of Homo-FRET. Upon energy transfer, the acceptor becomes 
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excited and it can emit radiation or energy can be dissipated as heat. Since the efficiency of FRET 
depends on the inverse sixth power of the distance between the donor and acceptor, it yields  
a detectable signal only when the two fluorophores are at a distance of at most few nanometers.  
FRET can therefore reveal whether suitably labeled proteins are at a distance that implies their 
physicochemical interaction. Technological advances in confocal microscopy imaging combined with 
the availability of genetically-encoded FPs and/or organic or quantum-dot (Qdot) based FRET pairs 
provide the tools necessary to detect protein interactions in living cells with high spatial and temporal 
resolution [72,73]. The spectroscopic properties that must be considered when selecting a workable 
FRET pair include sufficient separation in absorption spectra to avoid cross-excitation of the two 
fluorophores, overlap between the emission spectrum of the donor and the absorption spectrum of the 
acceptor to obtain efficient energy transfer, and separation in emission spectra between donor and 
acceptor to allow independent measurement of the fluorescence signal of each fluorophore. Several 
imaging techniques were applied to the evaluation of FRET efficiency [69]: Some of them are based 
on the quantification of donor and/or acceptor fluorescence intensities (e.g., sensitized emission, 
acceptor photobleaching), others on donor lifetime measurements (the latter decreases upon FRET 
occurrence). Another possibility is the measurement of FRET from sensitized acceptor depolarization 
upon donor excitation with polarized light (fluorescence anisotropy imaging). This last approach was 
used to investigate the dimerization of p75NTR at the cell surface of living cells using EGFP as 
fluorophore in a Homo-FRET experiment (see Section 3.2 and [33]). 
A different possibility to study interactions and clustering events in living cells (and possibly their 
dynamics) stems from techniques based on the measurement of fluorescence fluctuations whose 
ancestor is fluorescence correlation spectroscopy (FCS) but which was extended to study fluorescence 
fluctuations in and between whole images in a time lapse. These techniques typically exploit FP 
fusions of the protein of interest. One of the most exploited methods is the number and brightness 
analysis (N&B) [74]. This is based on the possibility of FCS to separate the brightness of a particle 
from the number of particles present in the observation volume and therefore to determine the  
degree of aggregation of proteins. This principle was exploited to obtain the N&B of diffusing 
molecules at each pixel of an image stack obtained with a laser-scanning microscope, so as to map  
protein-oligomerization states with high spatial resolution both at the cell membrane and inside living 
cells [75–78]. Concerning NRs, the N&B method was recently used to investigate the aggregation of 
intracellular p75NTR expressed in polarized epithelial cells (see Section 3.2 and [79]). 
As far as membrane and intracellular dynamics of NRs are concerned, this was studied by two 
different, complementary imaging approaches: (i) Ensemble or bulk fluorescence imaging and  
(ii) single-particle (SP) imaging and tracking. Ensemble imaging usually exploits laser-scanning 
confocal microscopes and typically measurements are performed on a bulk of molecules (most often, 
proteins) with fluorescent tags in order to describe their average diffusion features. Events like binding 
and confinement are usually inferred from their impact on diffusion. Fluorescence recovery after 
photobleaching (FRAP) [80] is the most famous of these techniques. Most typically, the protein of 
interest is fused to a FP and transiently or stably transfected in cells. A sub-region of the cell in which 
the fluorescent protein is localized is photobleached and the recovery of fluorescence intensity in the 
bleached area is followed as a function of time. The kinetics of this recovery is then used to retrieve 
quantitative information about the speed at which the fluorolabeled species diffuses from other regions 
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of the cell to the photobleached area [80]. A concern that is raised with FRAP is that it is a perturbing 
method, in that it requires high-intensity illumination to create the photobleached area thus potentially 
introducing undesirable effects like cell photodamage [81]. Furthermore, it is an averaging method, 
i.e., the properties of a large number of fluorescent particles are averaged in time and space. In order to 
overcome these drawbacks, FRAP studies were progressively replaced by single molecule imaging 
(SMI) approaches. In this case, the position of individual molecules out of a group is followed in time 
and the individual traced trajectories can be analyzed to extract quantitative information about particle 
movement. Trajectories can actually be signatures of the mechanism responsible for the observed 
molecule dynamics: these characteristics made SMI and SP tracking (SPT) appealing techniques for 
the study of a wide range of dynamic processes in living cells (e.g., membrane lateral movements [82], 
intracellular transport [83], viral infection [84], cytoskeleton rearrangements [85], nuclear dynamics [86]). 
We shall focus hereafter on the challenges posed by the study of protein dynamics at the cell  
plasma membrane. 
The application of SMI and SPT to the study of the dynamics of membrane proteins that can rather 
freely diffuse within the membrane requires a temporal resolution of at least some (tens of) milliseconds 
in a field of view that should contain a big part of the plasma membrane of the cell. Additionally, 
sensitivity and signal-to-noise ratio should allow the detection of the signal from individual single 
fluorophores. This is difficult to obtain through traditional confocal microscopy, but is instead 
achievable by wide-field microscopy coupled to fast electron-multiplying charge coupled device  
(EM-CCD) cameras. Often the time-resolved images are acquired from the basal membrane of the cell 
by means of total internal reflection fluorescence microscopy (TIRFM). This is a wide-field technique 
in which the collimated light of a laser is incident on the whole field of view at an angle such that it is 
totally internally reflected at the glass-water interface. As a consequence, only an evanescent wave 
penetrates the sample volume with an energy density that decreases exponentially moving away from 
the interface. Fluorophores are excited only in a region of the specimen immediately adjacent to the 
glass-water interface. This technique drastically decreases the background signal since fluorescence 
stemming from fluorescent molecules further away from the interface is suppressed. The depth of the 
illuminated region can be measured by the length parameter of the decreasing exponential function, 
which depends on the incidence angle of the laser but is usually ~100 nm, encompassing the basal 
plasma membrane and the cytoplasmic zone immediately adjacent to it. 
The choice of the fluorescent labels is very important when planning SMI and SPT measures, since 
detection of single molecules (SM) requires the use of bright and photostable fluorophores. The GFP 
fluorophore is widely used in ensemble imaging methods but displays poor photophysical properties at 
the SM level. Obtaining trajectories from GFP-tagged single proteins is feasible, but they are too short 
to allow the derivation of robust information about long-term diffusion as well as oligomerization  
state of the species of interest [87]. Usually labeling for SPT studies is performed with two different 
approaches. Proteins endogenously present at the plasma membrane can be detected using specific 
antibodies (or their Fab fragments), which can in turn be detected using secondary antibodies  
(or their Fab fragments): the primary or (if needed) the secondary antibody is usually conjugated to 
small organic dyes, gold nanoparticles, or fluorescent quantum dots (Qdots) [88–91]. If the proteins are 
membrane receptors, a possible alternative to antibodies is using their specific ligands conjugated to 
the same kind of probes [92–94]. In the second approach, the proteins of interest are fused to so called 
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“chemical tags”. This novel class of protein labeling strategies exploits defined polypeptide sequences 
that, once fused to the protein of interest, can be post-translationally modified with appropriately 
derivatized chemical reagents such as biotin or fluorescent dyes [56,58,61,95]. The labeling of most of 
chemical tags is compatible with living cells; therefore they are increasingly being used for live 
imaging purposes. Chemical tags are alternatively classified as: (i) Peptide or protein tags, depending 
on their size; (ii) self-labeling or enzyme-mediated-labeling tags, depending on whether their coupling 
occurs spontaneously or is enzyme-mediated; (iii) whole-cell-labeling or surface-labeling tags, 
depending on whether the chemical label is cell-permeable or not; and (iv) covalently or non-covalently 
conjugable tags, depending on whether the chemical probe can be attached covalently to the tag.  
As examples, the SNAP-, Halo-, and ACP- tags are protein chemical tags displaying peculiar 
chemistry of covalent conjugation that have been intensively used in recent years [58]. The use of 
chemical tags has the great advantage of ensuring a 1:1 stoichiometry between the protein of interest 
and the label. This is highly desirable when imaging and counting of SMs is needed, but it requires the 
ectopic expression of the tagged receptor in the cells, which may result in its over-expression and 
hamper the individual SM detection. Transgene expression should therefore be carefully controlled, 
e.g., using inducible promoters that can be exploited to avoid this drawback [96]. 
SPT raw data typically consist of time series of fluorescent spots moving in the imaged area with a 
frame recording time of the order of ms or µs. These data are analyzed by a two-step procedure that is 
often semi-automated to handle the great amount (hundreds to thousands) of trajectories. The first step 
consists in: (i) Identification of spots corresponding to SPs in each frame; (ii) their localization often  
at sub-diffraction and sub-pixel resolution; and (iii) connection of spots stemming from the same 
molecule in different frames, in order to build up the trajectory. This is typically performed with  
ad hoc tracking software tools. Today dozens of such software tools are available and were already 
reviewed [97] and a critical comparison of their output differences and similarities is available [98]. 
The second step is needed to compute biologically meaningful quantities from the obtained 
trajectories. Most typically, the first (and sometimes only) step in the quantitative description of  
a trajectory is the computation of the mean square displacement (MSD) against lag time [82].  
If a trajectory is self-similar (i.e., it undergoes only one type of motion), the trend of MSD identifies 
the type of motion described by the trajectory: Brownian (or purely diffusive), subdiffusive (e.g., 
localized), superdiffusive (e.g., drifted). Moreover, a linear fit on an appropriate number of the first 
MSD points yields a good estimate of the apparent diffusion constant D on the frame time scale [99]. 
Other fits can provide good estimates of confinement length [100], velocity of the drifted component 
of motion [100], the degree of anomalous diffusion [82]. MSD analysis does not always describe SM 
dynamics accurately. For example, SMs may not undergo a single kind of motion. In this case, two 
different approaches are used: (i) Estimate of global dynamic parameters from the whole set of 
trajectories (or from multimodal trajectories) by considering the entire probability distribution of 
square displacements (PDSD) [101] as a function of lag time; and (ii) classification of the trajectories 
in different categories that can also allow to monitor how different biologically-relevant treatments 
affect each diffusive category. Moreover, even within a single trajectory more than one type of 
dynamics may be present; a method for determining if a trajectory is “self-similar” is the evaluation of 
the linearity in the “moment scaling spectrum” (MSS) [102] that also provides a more robust estimate of 
the coefficient of anomalous diffusion; a second method relies on the measurement of possible 
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transient confinement zones (TCZs) versus free diffusion zones [103], from which the distribution of 
times in the two regimes (and therefore the kinetic constants for entering and exiting these zones) can be 
calculated. The MSS and TCZ analysis algorithms can even be combined to finally split multimodal 
trajectories into self-similar sub-trajectories or TCZ zones [104]. Another possibility is to monitor by  
a rolling-window analysis the trend of more than one parameter at a time (e.g., D, MSD curvature and 
asymmetry of motion [105]) in the same trajectory to detect transitions between different kinds  
of motion. 
From the analysis of the position trajectories it is also possible to quantify a monomer-dimer 
equilibrium, either by directly determining merging and splitting events between trajectories of 
different particles [89,92,106] or, when only a part of the “monomers” are labeled, by evaluating shifts 
in transient D within the same trajectory, e.g., by analyzing the cumulative square displacement (CSD) 
using a two-state hidden Markov model (HMM) [88]. In any case, the most reliable method to 
determine all oligomeric states displayed by a protein (and the time duration of each state) in living 
cells is simply the direct analysis of the number of fluorophores in each fluorescent spot [106]. This is 
feasible when there is a 1:1 fluorophore:monomer stoichiometry and all fluorophores are in identical 
excitation and emission configurations. In this case one can determine the number of fluorophores in 
each spot by the intensity of the corresponding signal [106,107]. Some significant examples of the 
wide range of biological information that can be extracted from SMI-SPT data are reported in Table 1. 
3. Advanced Imaging Approaches Applied to the Study of NR Dynamics,  
Trafficking and Signaling 
Several microscopy techniques were applied to study the dynamics of fluorescently-derived NRs 
and/or the respective ligands in living cells. The first reports addressed the intracellular trafficking of 
recycling or NT-activated NRs in terms of both local endocytosis and long-range axonal transport. 
Typically, GFP-fusions of NRs and NTs or fluorescent antibodies recognizing the extracellular 
epitopes of NRs were used for these purposes in time-lapse imaging experiments. The same GFP 
fusions of NRs were used in several FRET and bulk diffusivity measurements addressing the issue of 
homo- or hetero- di/oligomeric receptor complexes formation in living cells. More recently the 
conjugation of NTs or NRs to bright and photostable fluorophores together with the use of  
high-performance wide-field and video-rate microscopy have opened the way to studies of imaging 
and tracking of few or SM of the species of interest in living cells. Such approaches make it possible to 
probe membrane or intracellular diffusion, oligomerization state and axonal transport of NRs with 
detail down to the nanoscale. How advanced imaging approaches evolved in the study NT-NR 
intracellular dynamics and the main results obtained will be separately reviewed for the Trks and the 
p75NTR receptors in the following two sections. 
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Table 1. SMI-SPT analysis approaches to the study of membrane proteins. 
Membrane 
Protein 
Host Cell Labeling Strategy 
Applied Trajectory 
Analysis 
Biological Information Extracted References 
EGFR CHO Fab conjugated  
to Qdot 
CSD-HMM The EGFR monomer-dimer equilibrium is characterized:  
The receptor is found to exist in both states in resting conditions, with 
dimers primed for ligand binding and signaling. 
[88] 
CD36 Macrophages Fab conjugated to 
Cy3 or Qdot 
MSD; Anisotropy of the 
scatter of particle 
positions; MSS 
A subpopulation of receptors is identified, characterized by diffusion 
within linear confinement regions governed by cytoskeleton, whose 
peculiar geometry is found to promote receptor clustering as well as 
ligand-induced signaling and internalization. 
[89] 
FPR CHO Peptide ligand 
conjugated  
to Alexa594 
Analysis of  
spot intensities 
The GPCR monomer-dimer equilibrium is characterized with 
quantitative details: the two-dimensional monomer-dimer equilibrium 
constant as well as the association and dissociation rate constants  
are computed. 
[92] 
AMPA receptors 
(with GluR2) 
Primary 
hippocampal 
neurons from  
rat embryos 
0.5-μm latex beads 
coated with 
antibodies  
against GluR2 
MSD; TCZ; distance of 
trajectories from stained 
synaptic sites and 
endocytic pits 
During maturation or when raising intracellular calcium, the 
equilibrium between fast diffusion and stationary behavior of AMPA 
receptors is more and more shifted to the second state. Stationary 
zones often correlates with synaptic sites but not with clathrin-coated 
pits targeted by Eps15. It is suggested that diffusion can rapidly 
regulate receptor numbers at synapses. 
[108] 
GlyR Primary spinal cord 
neurons from 
Sprague Dawley  
rat embryos 
Biotinylated Fab 
against GlyR 1 
coupled to 
Streptavidin  
coated Qdots 
MSD fitting for 
Brownian and confined 
trajectories; 
reconstruction of 
trajectories from  
Qdot-blinking-induced 
shorter ones 
Cytoskeleton regulates the localization of GlyR and of gephyrin, the 
core scaffolding protein of inhibitory post-synaptic differentiation. 
Microtubules control GlyR lateral diffusion in the extra-synaptic 
membrane, actin at the synapses. 
[109] 
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Table 1. Cont. 
Membrane 
Protein 
Host Cell Labeling Strategy 
Applied Trajectory 
Analysis 
Biological Information Extracted References 
TrkA SH-SY5Y ACP chemical tag 
conjugated to Qdot  
or Atto633 
Analysis of combined 
distributions of 
parameters computed by 
MSD, MSS, and TCZ, 
and spot intensities 
analysis applied  
to trajectories  
and subtrajectories 
The interplay between TrkA oligomerization states, local diffusivity 
and degree of anomalous diffusion is investigated as a function of the 
binding of different ligands, showing that each ligand promotes 
distinct TrkA trajectory patterns (“ligand fingerprinting effect”,  
see Section 3.1). 
[104] 
β1-AR, β2-AR, 
GABAB receptor 
CHO SNAP chemical tag 
conjugated  
to Alexa647 
MSD;  
Analysis of  
spot intensities 
Three different GPCRs are found to exist at very different degrees of 
oligomerization (monomer-dimer for β1-AR and β2-AR, and  
dimer-tetramer for GABAB). The lifetime of such oligomeric states 
depend on receptor density but not on agonist stimulation. 
[106] 
CD59 T24, Ptk2, NRK Fab/IgG-gold,  
IgG-Cy3 or  
IgG-latex  
beads conjugates 
TCZ CD59 clusters were shown to undergo periods of actin-driven, 
stimulation-induced transient arrest of lateral diffusion (STALL),  
i.e., short-lived immobilization events throughout receptor 
trajectories. STALL events were correlated to the signaling of the 
receptor, via recruitment of activated PLCγ effector and subsequent 
IP3-Ca2+ spike under the STALL area. 
[110] 
AMPA receptors 
(with GluR2) 
Primary 
hippocampal 
neurons from  
rat embryos 
0.5-μm latex beads 
coated with 
antibodies  
against GluR2 
MSD; TCZ; distance of 
trajectories from stained 
synaptic sites and 
endocytic pits 
During maturation or when raising intracellular calcium, the 
equilibrium between fast diffusion and stationary behavior of AMPA 
receptors is more and more shifted to the second state. Stationary 
zones often correlates with synaptic sites but not with clathrin-coated 
pits targeted by Eps15. It is suggested that diffusion can rapidly 
regulate receptor numbers at synapses. 
[108] 
CD: cluster of differentiation; EGFR: epidermal growth factor receptor; FPR: N-formyl peptide receptor; AMPA: α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid; 
GluR2: glutamate receptor subunit 2; GlyR: glycine receptor; AR: adrenergic receptor; GABA: γ-aminobutyric acid. 
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3.1. Trk Receptors 
The real-time visualization of Trks trafficking and the evaluation of receptor dynamics in response 
to NT stimulus were addressed by several, complementary approaches. The first reports were based on 
GFP-fusions of Trks or of their ligands to study the bulk diffusivity of these molecular species in living 
neuronal cells. A GFP-TrkB construct was used for a FRAP study of axonal transport in DRG neurons 
grown in compartmented cultures [111]: GFP was photobleached in the soma compartment, and 
recovery of fluorescence monitored in response to 10 min of BDNF or control stimulation given at the 
neurite compartment. This study showed that in live neurons TrkB is rapidly and specifically transported 
to the cell bodies in response to NT stimulation of the neurites. Plasmids expressing BDNF-GFP were 
also used, in order to study the secretion dynamics of ectopically expressed NTs [112,113]. In another 
important study, EGFP fusions with TrkA were expressed in PC12 cells investigating both the  
full-length receptor and several deletion mutants progressively truncated in the intracellular domain 
(starting from the C-terminus). Authors reported the resulting trafficking between cell surface and cell 
interior in the presence or absence of NGF [114]. It was found that only the full-length protein 
properly moved among cell surface, plasma membrane ruffles, endocytic vesicles and perinuclear 
endoplasmic reticulum. Furthermore TrkA intracellular domain was found to contain two different 
trafficking motifs, one positively and one negatively regulating NGF-induced receptor internalization. 
Finally the last ~100 amino acids of TrkA C-terminus were found to be necessary for the lysosome 
degradation of NGF-activated receptors. Notably, in the same work confocal time-lapse analysis 
during NGF-induced differentiation made it possible to detect real-time transport of vesicles carrying 
activated full-length TrkA in anterograde and retrograde directions and to measure a transport velocity 
of ~0.5 µm/s in both cases. This recorded velocity is similar to that measured for radioactive  
iodide-labeled NGF in vivo [19,115]. However, as mentioned above, EGFP photo-physical properties 
make it difficult to resolve individual or few receptors [87,91,116]. The issue of transport was 
addressed in subsequent works, in which endogenously expressed TrkA was labeled with Qdots 
conjugated to the RTA anti-TrkA antibody, a known partial agonist for this receptor [117]. This led  
to the visualization of receptor bidirectional movements in NGF-differentiated PC12 cells [118].  
Qdot-RTA-TrkA molecules were found to move in vesicles displaying velocities of the same order of 
the ones previously reported (~0.24 µm/s), but in this case small clusters of receptors in each tracked 
fluorescent spot could be distinguished thanks to the brightness and blinking properties of the  
probe [118]. However, whether these EGFP- [114] or Qdot-TrkA [118] filled vesicles indeed 
correspond to signaling endosomes could not be conclusively proved in these studies since the 
neurotrophin itself was not fluorescent. This limitation was overcome with the preparation, validation 
and use of various labeled-NGF probes to be used in tracking studies in living cells, the main of which 
are reported in Table 2. Two main strategies were adopted to (fluoro) label NGF: (i) Chemical 
modification of NGF at free carboxyl groups using reactive biotin- or organic dye-probes; this was the 
most widely used NT-labeling approach, even if it suffers from the lack of control in the number and 
type of modified sites of the target proteins; (ii) fusion of the sequence of NGF to that of a chemical 
tag that will be covalently coupled to the probe of interest. The latter approach has the advantage of 
ensuring a 1:1 probe-NT stoichiometry. 
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Table 2. List of the main labeled NGF (nerve growth factor) derivatives reported in literature. 
NGF Labeling Strategy Ratio of Probes Per NGF Molecule 
Cellular Model Testing  
NGF Activity 
References 
125I-NGF n.d. Sympathetic neurons [115] 
Biotinylated NGF (NGF-b) ~3 biotin molecules per NGF subunit PC12 [119] 
NGF-b/Streptavidin 
Alexa647 
~9 biotins per NGF molecule; 20 nM NGF-b is given to the cells and further 
detected with Streptavidin Alexa647 
PC12 and PC12nnr5 [120] 
NGF-b/streptavidin Qdot 
≤3 biotins per NGF subunit; NGF-b is conjugated to streptavidin-Qdot at a 
molar ratio of 1 NGF:1 Qdot 
PC12 [121,122] 
~1 biotin was bound per NGF molecule; 2nM NGF-b is given to the cells 
and further detected with 50–500 pM streptavidin-coated Qdot 
Differentiated PC12 [123] 
~3 biotins per NGF dimer; NGF-b is conjugated to streptavidin-Qdot at  
a molar ratio of 1 NGF:1 Qdot 
Rat DRG neurons [83] 
Cy3-NGF or Cy3.5-NGF ~1.0–1.1 ratio between fluorophore and NGF Chick embryonic DRG neurons; PC12 [124–126] 
Mono-biotinylated NGF 
via chemical tag 
AVI-tag fused at NGF C-terminus; NGF-b is obtained transfecting the 
construct in HEK293FT cells together with the biotinylating BirA enzyme; 
NGF-b is conjugated to streptavidin-Qdot at a molar ratio of 1 NGF:1 QD 
Rat DRG neurons [127] 
A4-tag fused at NGF C-terminus; NGF-b is obtained by labeling the 
purified protein with CoenzymeA-biotin substrates and PPTase enzyme 
PC12 [128] 
Qdot: quantum-dot. 
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The membrane movements of NGF-TrkA complexes and their trafficking upon endocytosis were 
investigated at the SM level by using fluorescent cyanine derivatives of NGF [124,125]. Cy3-NGF at 
sub-nM concentration was monitored in the growth cones of chick dorsal root ganglion: within 1 min, 
only 40 molecules of ligand were found bound to receptors exposed at the growth cone, first moving 
on the membrane with a diffusion constant of 0.31 μm2/s and then shifting to a drifted, actin-driven 
rearward movement toward the central region of the growth cone at ~4 μm/min rate. Authors 
suggested that this rearward trafficking movement precedes NGF-receptor complex internalization in 
the vicinity of the central region of the growth cone. Actin-driven trafficking of the NGF receptor 
complex was thus proposed to be an essential step for the accumulation and endocytosis of NGF at the 
growth cone and for the retrograde transport of NGF towards the cell body [124]. In a parallel work, 
the same probe was used to investigate the spatiotemporal properties of ligand-receptor complexes 
formed at the plasma membrane of living PC12 cells: Recorded trajectories typically revealed two 
distinct transient modes of movement, characterized as mobile phase and immobile phase, with abrupt 
switching between the two. Notably, the immobile fragments of the trajectories were found to 
correspond to clustered NGF complexes, to depend on the receptor kinase activity and to co-localize 
with the signaling effectors recruited under the plasma membrane. Therefore NGF immobilization at 
the cell membrane was related, albeit indirectly, to the start of signal transduction by activated  
NRs [125]. Alternatively, NGF conjugated to Qdots was widely used for the long-term imaging of 
ligand-receptor complexes once internalized into cells [83,118,121,123]. These studies were crucial  
for the understanding of the details of NGF axonal transport in live DRG neurons [83], of NGF 
bidirectional movements in the neurites of PC12 cells [123], and of NGF-receptor complexes during 
endocytic trafficking [121]. In the latest work of this series a GFP fusion of TrkA (TrkA-mSEGFP) 
and a Cy3.5-NGF conjugate were used in imaging experiments in PC12 cells. TrkA-mSEGFP  
was found to undergo increased directional (both anterograde and retrograde) movements upon  
NGF application. Interestingly, the average speed of TrkA-mSEGFP associated with Cy3.5-NGF 
(anterograde velocity peaks: 0.45–1.50 µm/s; retrograde velocity peaks: 0.45–1.23 µm/s) was 
remarkably higher than that of TrkA-mSEGFP alone (anterograde velocity peaks: 0.30–1.10 µm/s; 
retrograde velocity peaks: 0.18–0.45 µm/s). Moreover, co-localization of TrkA-mSEGFP with  
Cy3.5-NGF was found to occur more frequently in retrogradely moving vesicles than in anterogradely 
moving ones [126]. The intracellular dynamics of NGF-TrkA complexes was therefore rather 
extensively investigated, but the study of BDNF-receptor complexes is only starting to be addressed. 
The axonal movements of Qdot-conjugated BDNF after NR-NT internalization was described in 
living, compartmented hippocampal neurons and showed that BDNF is transported retrogradely with  
a mean velocity of ~1 µm/s within both endosomes and multi-vesicular body-like structures [129]. 
More recently, Vermehren-Schmaedick et al. [130] used Qdot-conjugated BDNF to study the 
recycling and intracellular trafficking of internalized BDNF-receptor complexes in the neuronal soma 
of nodose ganglion sensory neurons. Differently from the reported linear nature of axonal transport, 
authors found that trafficking of BDNF complexes at the cell soma is extremely heterogeneous. 
Reported trajectories in this compartment show no apparent end destination, little time-synchrony and 
high heterogeneity, e.g., sustained rapid motor transport without pause and immobility for minutes. 
Data are noteworthy in that they suggest that, whatever the origin, the destiny of NT complexes 
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arriving to the cell soma is by no means trivial and that mechanisms leading to gene expression 
activation by BDNF need be carefully identified. 
The combination of bulk, EGFP-based and SM, Qdot/organic dye-based imaging studies yielded 
valuable information about the intracellular fate of activated NGF receptor complexes. Nevertheless, 
none of the cited works addressed the molecular details of NT-induced Trks membrane mobility and 
early steps of receptor internalization at, or close to, the cell membrane. Similarly, the oligomeric state 
of Trks in response to NT binding was only briefly addressed. The main reasons for this are at least 
three: (i) By GFP fusion to the TrkA receptor both the intracellular and membrane pools of protein are 
labeled and discriminating the two of them requires the use of high resolution imaging techniques such 
as TIRF microscopy [65]; (ii) the GFP fluorophore displays poor photophysical properties at the 
single-molecule level and tracking of GFP-tagged single receptors is not feasible for long-enough time 
to retrieve reliable information about the oligomerization state [87]; and (iii) the alternative use of 
fluorophore-conjugated NGF only allows the study of TrkA receptor in its activated form, likely in the 
presence of p75NTR co-receptor, so that the net effect of ligand binding on the membrane mobility of 
a single receptor is simply not possible. 
In order to avoid these drawbacks, a method was developed that makes it possible to quantitatively 
investigate the dynamics of individual TrkA receptors in living cells selectively at the cell membrane 
and independently of its ligand-binding state. In detail, the TrkA cDNA sequence was engineered by 
adding the ACP (acyl carrier protein) tag sequence [95] to the extracellular domain of TrkA downstream 
the signal peptide (Figure 2) [100]. More recently, shortened versions of the ACP tag were also 
inserted that are only 12 amino acids long but yield the same labeling of the full length tag [128]. 
Together with its cognate PCP (peptidyl carrier protein), the ACP tag is the ancestor of a family of 
protein and peptide chemical tags, which can be covalently conjugated to virtually any small-probe 
substituted phosphopantetheinyl (PP) arm of Coenzyme A (CoA) substrate by post-translational 
modification enzymes named PP transferases (PPTases) [57,61,95]. Some of these may also allow 
orthogonal labeling of different proteins [128,131]. This tag thus yields site-specific receptor labeling, 
either with highly stable Qdots or with organic dyes. The ACP-TrkA construct was expressed in  
TrkA-deficient PC12nnr5 cells, it was selectively biotinylated at the cell surface using CoA-biotin 
substrate by addition of PPTases into the cell medium, and finally conjugated to Streptavidin-coated 
single Qdots. This strategy made it possible to track the labeled receptors with single-molecule resolution. 
The tag was shown not to interfere with TrkA receptor function, as the recombinant labeled receptor 
fully preserves TrkA biochemical and signalling functions, including clathrin-mediated internalization 
upon NGF addition. Moreover, a preliminary SPT analysis of single fluorescent ACP-TrkAs identified 
heterogeneous diffusion patterns for this receptor in this cell line [100]. Membrane mobility of labeled 
ACP-TrkA was also investigated by using TIRF microscopy combined with SPT analysis and the 
single-molecule dynamics of ACP-TrkA at the membrane of living SH-SY5Y neuroblastoma cells was 
reported in resting conditions and after binding to four different biologically-relevant ligands for TrkA 
(see Figure 2 and [104]). 
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Figure 2. Schematic picture of four different NTs binding to ACP-TrkA. The ACP-TrkA 
construct and the four ligands investigated for receptor binding [104] are schematically 
depicted. NGF, NGF R100E mutant (mutNGF, related to HSANV disease [132]), proNGF 
and NT-3 all bind to the extracellular domain of TrkA receptor but with different affinity, 
as quantified by the Kd (dissociation constant) values (see the color-coded arrowheads 
referring to the corresponding Kd values, which are taken from: ≠ [133]; * [134]; † [135]). 
The evoked physiological responses are also different among the four ligands and are 
summarized at the C-terminus of the receptor, highlighted by arrowheads with the same 
color-code. Intracellular effectors recruited at phosphorylated tyrosine residues and leading 
to the activation of the MAP kinase, the Akt and PLCγ signaling pathways, upon TrkA-NT 
binding are also schematically depicted. The numbering of tyrosine residues refers to the 
rat TrkA cDNA sequence. Note that while Y499 and 794 only have recruitment function, 
Y683/4 constitute with Y679 (not depicted) the activation loop of tyrosine kinase activity. 
The figure has been adapted from [104]. 
The four investigated ligands (NGF, NGF R100E HSANV mutant, proNGF and NT-3) are all TrkA 
agonists and display peculiar signaling outcomes [104]. Using Qdot- and Atto633-based receptor 
labeling for tracking and stoichiometry measurements respectively, it was found that, at low expression 
levels, most of unstimulated TrkA receptors are fast moving monomers characterized by an average 
diffusion coefficient of ~0.5 µm2/s, about 20% TrkA molecules are moving at least an order of 
magnitude slower and likely correspond to dimeric and oligomeric states, and around 4% are almost 
immobile within regions of about 0.6 µm diameter. Ligand binding results in substantial immobilization 
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and slowing down of the receptors, together with an increase of the dimeric and oligomeric populations, 
consistently with the activated receptor being involved in trans-phoshorylation and subsequent 
interaction with intracellular signaling effectors. Only upon administration of NGF, the fast-diffusive 
population was observed to consist of monomeric and dimeric forms in dynamic equilibrium, with the 
latter seemingly moving with almost halved D (~0.3 µm2/s) with respect to the former ones; in the 
same condition, up to 8 TrkA molecules could be counted per slow and confined tracked spots. To be 
noted that the oligomerization state of the receptors was analyzed using only fluorophores (at a 1:1 
stoichiometry with the receptor) at a concentration high enough to achieve almost complete labeling, 
and all experiments were performed in cells displaying low expression of ACP-TrkA (some units up to 
few hundreds of molecules on a region in the basal membrane of the order of 103 μm2). Crucially,  
the extent of TrkA lateral mobility modification is strictly ligand-dependent and each ligand promotes 
distinct trajectory patterns of TrkA receptors at the cell membrane. We called this “ligand-fingerprint 
effect” and by inducing a set of biochemical modifications of the cell environment, affecting receptor 
kinase activity, clathrin-coated pits formation, or actin-meshwork integrity, investigated its molecular 
basis [104]. A close correlation was demonstrated between the initial receptor-membrane dynamics 
triggered upon ligand binding and the specific biological outcome induced by different ligands for the 
same receptor. 
The observation that NGF addition causes a reduction of the fast diffusing population and a shift  
of the monomer-dimer equilibrium towards dimeric and clustered forms strongly supports the model  
of ligand-induced TrkA di-/oligo-merization. Such conclusion may appear in disagreement with  
data previously reported on the presence of TrkA and TrkB “inactive” dimers independently of NT  
binding [136,137]. In those articles, the existence of Trks dimers in resting conditions were assessed 
by using a combination of bimolecular-fluorescence and luciferase-fragment complementation assays 
of recombinant receptors ectopically expressed, together with chemical crosslinking of cell surface 
receptors. NT addition was only found to increase dimer phosphorylation, but not the overall dimer 
population. Since such “inactive” TrkA dimers would not be involved in any interaction with intracellular 
signaling effectors, one is led to assume that they would be freely moving at the cell membrane.  
Our analysis shows that if these dimers indeed exist, they are not stable enough to be tracked by our 
experimental set up, contrary to what happens upon NGF administration. Another possibility is that, at 
the low receptor expression levels analyzed, we could be abundantly below the dissociation constant 
(Kd) of the monomer-dimer equilibrium in resting conditions, so that we are able to detect only 
monomers; upon NGF addition, the Kd becomes lower and a significant amount of fast moving dimers 
can be detected. Possibly, it could also be that TrkA concentration at the membrane in previous 
experiments [136,137] was higher than the resting Kd, or the latter was decreased by the used 
experimental techniques, leading to the detection of preformed dimers. As for slowing-moving  
dimers and oligomers, they are not only strongly induced by NGF addition but also constitute ≈20% of 
TrkA trajectories in resting conditions: these may be possibly linked to constitutive internalization  
and recycling or to transactivation [104]. In any case, it is most likely that some of the discrepancies 
between the SPT studies and previous cross-linking studies may be explained by the strong 
dependence of the actual Trks monomer-dimer-oligomer equilibrium either in resting or stimulated 
conditions, on the receptor expression level as well as by the cell line in which experiments are 
performed. Indeed, this scenario is well established for the ErbB family (among which, the EGFR  
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was most intensively studied) of RTK: indeed, different advanced-imaging approaches allowed the 
detection of different receptor-monomer/dimer ratios in resting conditions (see e.g., [88,138–140]), 
depending on the expression level of the investigated receptor. The number of expressed receptors  
was also linked, together with ligand binding, to the switch from inactive to active EGFR dimers,  
via a mechanism involving receptor interaction with the cell membrane [141]. 
3.2. p75NTR 
Although p75NTR was the first NGF receptor to be identified, and its transport along axons was 
described before that of Trks [14], studies investigating its intracellular and membrane dynamics using 
advanced imaging approaches are far less numerous than those reported for the Trks. The earliest 
articles in the field addressed p75NTR intracellular kinetics and route of NT-induced internalization  
by confocal microscopy in PC12 cells as well as in motor neurons [120,142]. Live-cell studies  
were performed using biotinylated NGF (further coupled to fluorescent streptavidin) and/or  
a fluorophore-conjugated anti-p75NTR antibody recognizing its extracellular domain. These studies 
established that NGF-p75NTR internalization occurs at a rate approximately three times slower than 
that of NGF-TrkA complexes in PC12 cells [120]. Interestingly, and differently from TrkA, in motor 
neurons p75NTR internalization rate was found not to be affected by NT addition to the cell medium; 
rather, the NT effect was that of re-directing the internalized p75NTR pool from non-coated to 
clathrin-coated vesicles, which would then be routed to axonal transport [142]. Although sharing  
the same clathrin-dependent endocytic route, differently from TrkA-filled vesicles, the internalized  
NTs-p75NTR complexes were observed to be mostly protected from proteolytic degradation and to 
accumulate in vesicles that did not undergo acidification. These would be later found, both in PC12 
cells and sympathetic neurons, to be either recycling endosomes or multivesicular bodies targeted to 
exosomal release [143]. As these vesicles were found to contain also signaling effectors, the authors 
finally proposed that NGF-p75NTR signaling endosomes exist, and that such endosomes may be either 
spatio-temporally and functionally distinct from those containing Trks. The existence of endosomes 
carrying p75NTR transported by microtubule-associated motors was further proved by the use of a 
GFP-tagged version of this protein expressed in live cortical and hippocampal neurons. In this case, 
authors were able to measure a mean velocity of 0.1–0.5 µm/s for anterogradely moving p75NTR 
vesicles, and of 0.1–1 µm/s for retrogradely moving vesicles [144]. More recently, a Halo tag [145] 
fusion of p75NTR was reported that was expressed in compartmented cultures of rat sympathetic 
neurons to monitor its retrograde transport during NGF and BDNF retrograde signaling [146].  
The Halo tag belongs to the family of chemical tags [57,61,145] that are preferable to GFP tags for 
SMI purposes. When fused to recombinant proteins expressed in living cells the Halo tag can be 
covalently fluorolabeled by adding haloalkane-derivatives of organic dyes into the cell medium.  
The main advantage of this method is that it allows selective, separate labeling of transfected proteins 
in the distal axons or cell bodies/proximal axons of compartmented neurons: this makes it possible to 
independently monitor particles moving along axons in one direction. 
Advanced microscopy techniques much helped gaining key insight on p75NTR activation at the cell 
membrane in response to ligand binding. Vilar et al. [33] showed that p75NTR exists both when 
endogenously or ectopically expressed as pre-formed dimers at the cell membrane independently of 
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ligand binding. The dimer/monomer ratio of cell surface p75NTR was measured by biochemistry 
methods (biotinylation of cell surface receptors, p75NTR immunoprecipitation, non-denaturing gel 
electrophoresis and blot) and was shown to vary in different cell types and with different levels of 
receptor transfected. Such dimeric state was found to rely on the AXXXG motif of the receptor 
transmembrane domain, and to be crucially stabilized by the formation of a disulfide bond between 
two cysteine residues belonging to the same domain (Cys257, depicted in Figure 1B). Mutation of 
Cys257 to alanine did not alter the dimeric state of the receptor but abolished neurotrophin-dependent 
receptor activity. Authors proposed that these covalent p75NTR dimers are the molecular species able 
to transduce NT signals. In the same work, FRET experiments were performed with a p75NTR-EGFP 
construct expressed in living COS-7 cells, in which the degree of receptor self-association was 
monitored as change of fluorescence anisotropy signal due to homo-FRET between adjacent EGFP 
fluorophores. These experiments demonstrated a close association of the intracellular domains for both 
wt (wild-type) and Cys257-mutated p75NTR, consistently with the existence of receptor dimeric  
forms in the two cases. Intriguingly, NGF addition resulted in a significant increase of anisotropy for 
the wt but not for the mutant receptor, stemming from a decrease of FRET between two adjacent 
fluorophores. Authors suggested that rather than a dissociation of p75NTR into monomers (which is 
not feasible in the scenario of covalently-linked dimers), NTs activate p75NTR by a mechanism 
involving separation of the intracellular domains of disulfide-linked receptor subunits, with Cys257 
acting as the pin of the “dimer scissor” [33]. In a separate work the same authors suggested that such 
separation of intracellular dimer domains is concomitant to the closure of the dimer extracellular 
domains upon NT binding [32]. The correlation between p75NTR dimerization and its function,  
in particular its cleavage by γ-secretase as the final step of regulated intramembrane proteolysis [147,148], 
was further investigated in living cells by FRET microscopy [149]. In this work, authors set up  
a sophisticated high-throughput cell-population-based FRET assay with multimode plate readout, 
using the CFP-YFP FRET pair. The two FPs were fused to a number of different p75NTR constructs, 
with deletions and/or mutations all along the receptor sequence that were expressed two at a time in 
HEK293 cells. Measurements were also performed in the presence of p75NTR co-receptors like  
TrkA, sortilin, and upon addition of NGF or proNGF as ligands. FRET measured for the full-length  
p75NTR-CFP co-expressed with the respective YFP counterpart was used as an estimate, albeit 
indirect, of the dimerization degree of the receptor. Authors showed that the transmembrane domain of 
p75NTR is sufficient for dimerization, which in turn favors the occurrence of regulated intramembrane 
proteolysis. The structural changes caused or permitted by Cys257-mediated disulfide bond were 
shown to facilitate γ-secretase cleavage, thus correlating dimer-mediated cell death signaling to  
the generation of the intracellular domain fragment, as independently assessed by biochemistry assays 
in neurons [150]. On a side note, authors observed that the co-expression of TrkA, but not sortilin, 
promotes an increase of p75NTR dimerization, and that TrkA activation promotes the dissociation  
of p75NTR C-terminal fragment dimers through facilitation of γ-secretase cleavage. Finally, and 
unexpectedly, both NGF and proNGF did not appear to have any influence on the dimerization degree 
of p75NTR. In conclusion, the NT-induced dynamics of p75NTR appears to be quite different from 
that of TrkA that is dramatically slowed down upon NGF administration [104,125]. If the interaction 
of p75NTR with TrkA seems to likely involve their intracellular domains [46,149], this appears not to 
be the case for p75NTR-sortilin interaction: the same group, using the same cell-population FRET 
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assay, proved that the extracellular stalk JM domain (Figure 1B) is necessary for p75NTR interaction 
with sortilin [151]. It must be pointed out that all the cited studies provide an indirect estimate of 
p75NTR dimerization obtained by means of FRET-related techniques. The recent development of 
p75NTR constructs functionalized with short peptides derived from ACP/PCP tags will allow to 
directly investigate on the oligomerization state and dynamics of this receptor on the cell membrane, 
analogously to what previously reported for TrkA [128]. 
Recently the role of p75NTR dimerization was also studied in a non-neuronal context, i.e., for the 
case of the apical sorting undergone by this receptor in polarized epithelial cells [79]. In this work, 
fluorescence fluctuation techniques (photon-counting histogram and N&B analyses [74]) were used  
to study p75NTR oligomerization status in living cells and to correlate it to receptor polarized 
localization. Authors found that a GFP fusion of the wt receptor (with EGFP fused at the C-terminus of 
the receptor) forms clusters (up to ~9 receptor molecules per cluster) in the trans-Golgi network 
(TGN) but not at the plasma membrane. Although authors did not investigate further on the p75NTR 
oligomerization status at the cell surface, they found that the dimerization motif plays a crucial role in 
inducing receptor clustering, because mutant receptors having dimerization or O-glycosylation at the 
JM domain impaired displayed neither clustering nor selective apical targeting. 
4. Conclusions and Future Perspectives 
The rapid development of advanced fluorescence imaging techniques has required input from 
biologists and chemists that have provided new fluorescent probes spanning from fluorescent proteins 
to semiconductor Qdots, and physicists that improved microscope set-ups and analysis software. These 
contributions led to the unprecedented probing of the nanoscale details of several cellular processes. 
With these tools in hands, much knowledge was added to the puzzling fate of activated NT-NR 
complexes within compartments spanning from the neuronal cell membrane to the cell body. 
First of all, the details of NR dynamics at the plasma membrane started to be elucidated both in 
resting conditions and following ligand stimulation. This is an important step towards the complete 
understanding of the NT-NR interaction network. NT-activated signaling pathways are always the 
meeting point of several different NTs (and/or their respective precursor forms) binding to different 
ratios of NRs and/or cognate receptors present at the cell surface of different neuronal cells. Such 
diversification accounts for the many pathophysiological events in which NTs are involved, but its 
molecular basis has remained so far unclear. No doubt that a compelling picture of NT function will 
require inputs from different neuroscience disciplines; nevertheless, we point out here that SMI and 
SPT approaches applied in turn to the study of the different players involved may allow to identify the 
molecular species (and related stoichiometry) formed at the cell membrane, which could account for 
these differential signaling outcomes. Importantly, the behavior of these receptors at the cell membrane 
represents a first, specific target for pharmacological approaches in a broad range of neurological 
indications [26]. Thanks to the availability of chemical tags, NRs expressed at the plasma membrane 
can be labeled with fluorophores that are suitable for SMI purposes so that it is now possible to obtain 
information about receptor dynamics and oligomeric state at the cell membrane. This led to the 
observation reviewed here that different NTs binding to TrkA receptor lead to ligand-specific changes 
of the lateral mobility of single-receptor molecules [104]. Given the sensitivity displayed by the SPT 
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readout of TrkA dynamics upon different stimuli, one can surmise that this assay may be suitable for 
the screening of compounds selected against this receptor. Furthermore, the “ligand-fingerprint” effect 
is a significant result to be cast within a broader scenario recently emerged. The specific influence of 
different ligands for the same receptor was poorly investigated by SMI, as far as receptor  
dynamics is concerned, and limited to a comparison between agonist and antagonist ligands for  
the same G protein-coupled receptor [152]. However, specific ligand-receptor signatures, defined as  
receptor-specific programs of signaling events, were recently reported to regulate different physiological 
states of phagocytic cells, ultimately leading to the regulation of the whole process of phagocytosis [153]. 
The discovery of a ligand signature in the receptor membrane dynamics opens the way to several 
future investigations. Molecular mechanisms linking the different extent of NT-induced receptor 
clustering and immobilization at the cell membrane to their respective different biological outcomes 
must be clarified; likely, these involve endosome organization, sorting and trafficking induced by 
internalized NT-NR activated complexes [11]. Furthermore, it will be interesting to investigate 
whether the dynamic fingerprint concept can be generalized to other receptors: indeed, there may be  
a causal correlation between dynamic fingerprints at the cell membrane and the downstream activated 
signaling pathway. Ligand-induced lateral movements could be conserved or differentiated among 
different receptors sharing the same signaling pathways, thus providing a molecular key to understand 
how different growth-factor receptors achieve molecular specificity by using apparently identical 
signaling cascades. 
Although Trks and p75NTR belong to two completely different receptor families, from the work 
reviewed here they appear to share similar activation events at the cell membrane, among which 
dimerization is crucial for neurotrophin signaling. In this context, Trks behavior is consistent with that 
of the other members of the RTK superfamily, such as the ErbB receptors. However, given the 
diversity displayed by both structure and ligand-binding modes of ErbB and Trk receptors [154], 
whether the latter display the same inactive-to-active dimer switch as EGFR during ligand-induced 
activation remains to be established. Different experimental approaches addressing the question of 
receptor expression level in living cells more systematically must be undertaken. Also, alternative 
algorithms for SM-trajectory analysis that can detect both short- and long-lived receptor di-/oligo-meric 
states and possibly link them to their dynamics would much help this analysis; this approach might 
finally reconcile the two hypotheses of preformed TrkA dimers and of stabilization of dimerization 
upon ligand binding. These studies should be supported by structural analysis of the re-organization of 
intracellular domains of the Trks following ligand binding. 
p75NTR appears like an anomalous member of the TNFR superfamily that mostly comprises 
receptors that bind trimeric ligands to induce the trimer- or oligo-merization of their intracellular death 
domains. p75NTR instead binds to dimeric neurotrophins and its dimerization is functionally 
significant for neurotrophin signaling. What is still not clear is whether ligand-bound p75NTR dimers 
undergo clustering at the cell surface, if this depends on available p75NTR co-receptors, and if this is 
relevant to achieve complex internalization. Furthermore, how the dimeric and possibly oligomeric 
p75NTR forms relate to the respective NGF-activated TrkA forms at the cell membrane still needs 
exploration. Indeed, there surely is a differentiation in the intracellular routes undertaken by these two 
receptors upon activation, proved by their well-established distinct internalization kinetics. Events 
occurring at the cell membrane and resulting in the dissection of TrkA and p75NTR signaling 
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outcomes constitute an exciting future challenge for SMI of NRs in living cells, and will be likely 
feasible using a novel imaging toolbox that allows independent and simultaneous tagging of NRs and 
their ligands [128]. 
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